Delivery schedule

Lu-177 n.c.a delivery interruption

Wednesday 19 March 2025

We are writing to advise that due to an issue encountered in the current production run, there will be an interruption to Lu-177 n.c.a supply over the coming weeks.
 
Deliveries scheduled for this week (w/c 17 March) have been completed and fulfilled.  
 
However, we wanted to notify you as soon as possible about the following supply changes:
 
Week commencing 24 March: Some customer orders cannot be fulfilled and those customers have been contacted directly.
 
Week commencing 31 March: No supply will be available from ANSTO.
 
Please note: A back-up supply of Lu-177 from an international partner is unavailable. However, supply is confirmed for week commencing April 7.
 
The ANSTO nuclear medicine supply team is contacting affected customers directly. Please check the customer portal for your individual delivery schedule.
 
ANSTO apologises for this inconvenience to you and your customers.  

If you have any questions, please reach out to our team at [email protected].

The Health team at ANSTO

Tc-99m Gentech Generator delivery update

15 March 2025

On Thursday 13 March 2025, ANSTO notified you that a batch of Molybdenum-99 failed our stringent quality testing, affecting orders of Gentech® Generators.

A new batch of Molybdenum-99 has now been produced and met the quality standards. Gentech® Generators for the domestic market are scheduled to be manufactured and dispatched on Monday 17 and Tuesday 18 March 2025.

As we return to normal operations, customers will experience delays to their usual delivery days. Please check the customer portal for your individual delivery schedule.

The ANSTO Nuclear Medicine team will be contacting impacted customers directly.

If you have any questions, please reach out to our team at [email protected].

The Health team at ANSTO

13 March 2025

ANSTO is notifying customers of a delay affecting our supply of Tc-99m Gentech® Generators. Unfortunately, a batch of Molybdenum-99 failed our stringent quality testing. As such, we are unable to fulfill orders scheduled for delivery on Friday, 14 March 2025. 

Please note that this delay may result in minor disruptions to customer deliveries into the week commencing 17 March 2025.

ANSTO will continue to provide updates as they become available.

If you have any questions, please contact our team at [email protected].

The Health team at ANSTO

Planned maintenance notification

10 February 2025

As part of our annual planned maintenance schedule, ANSTO will temporarily cease nuclear medicine manufacture from Monday 05 May to Sunday, 01 June 2025.

These maintenance shutdowns support the ongoing safe operations and reliable supply of nuclear medicine to our customers.

Product Availability

If you have any questions, please reach out to our team at [email protected].

The Health team at ANSTO